With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

Silas Zindel—13PHOTO/Redux Early in Vas Narasimhan’s career as a physician scientist, he worked on programs for treating HIV/AIDS in Africa and saw the impact of medicine in places that need ...

Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals get in the way of its progress. With recent indication additions, breast ...

Vas Narasimhan, the CEO of Novartis, discusses the Swiss pharmaceutical company's first-quarter earnings. Hillary Clinton breaks silence on Trump’s controversial $400m Qatari jet I’ve been a ...

May 8, 2025 – Today, TIME reveals the second annual TIME100 Health list recognizing the 100 most influential individuals in ...

The comprehensive restructuring of Novartis under new CEO Vas Narasimhan resulted in $15 billion in bolt-on acquisitions last year, and he wants to keep up that momentum. Speaking on Novartis ...

"Even in this I think complex geopolitical environment, we feel confident we can deliver now this upgraded guidance," CEO Vas Narasimhan told CNBC's "Squawk Box Europe" on Tuesday. Sales continued ...

Novartis’ new CEO Vas Narasimhan has shown his priorities by promoting the company’s digital chief to the executive committee. New broom and chief digital officer Bertrand Bodson has been ...

Vas Narasimhan is global head of drug development and chief medical officer at Novartis, and spoke to pharmaphorum at the company’s recent Q4 results conference. He says numerous pilot studies ...